CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 78.1% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English

Trade Black Diamond Therapeutics, Inc. - BDTX CFD

4.6915
1.68%
  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading сonditions
Spread 0.0270
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.026179 %
Charges from full value of position ($-1.05)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Go to platform
-0.026179%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.003957 %
Charges from full value of position ($0.16)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Go to platform
0.003957%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency USD
Margin 20%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

Black Diamond Therapeutics Inc ESG Risk Ratings

High Medium Low Negligible

‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.

More ESG coverage

Key Stats
Prev. Close* 4.7715
Open* 4.8615
1-Year Change* 204.3%
Day's Range* 4.6915 - 4.8915
52 wk Range 1.22-6.85
Average Volume (10 days) 389.12K
Average Volume (3 months) 9.41M
Market Cap 140.96M
P/E Ratio -100.00K
Shares Outstanding 51.64M
Revenue N/A
EPS -2.13
Dividend (Yield %) N/A
Beta 2.58
Next Earnings Date Mar 7, 2024

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Mar 18, 2024 4.6915 -0.0900 -1.88% 4.7815 4.9315 4.6515
Mar 15, 2024 4.7715 0.2100 4.60% 4.5615 5.0015 4.4915
Mar 14, 2024 4.5115 0.3200 7.63% 4.1915 4.6315 4.1415
Mar 13, 2024 4.1815 0.4100 10.87% 3.7715 4.2515 3.6915
Mar 12, 2024 3.7615 -0.1800 -4.57% 3.9415 3.9815 3.6915
Mar 11, 2024 3.9815 -0.0300 -0.75% 4.0115 4.1715 3.9515
Mar 8, 2024 4.0615 -0.1000 -2.40% 4.1615 4.4215 4.0415
Mar 7, 2024 4.1815 -0.1800 -4.13% 4.3615 4.5515 4.1515
Mar 6, 2024 4.4115 0.1000 2.32% 4.3115 4.5215 4.3115
Mar 5, 2024 4.3915 0.0300 0.69% 4.3615 4.4815 4.3015
Mar 4, 2024 4.4915 -0.3100 -6.46% 4.8015 4.8515 4.4515
Mar 1, 2024 4.7615 -0.3700 -7.21% 5.1315 5.3215 4.6515
Feb 29, 2024 5.1315 -0.0100 -0.19% 5.1415 5.2515 4.9515
Feb 28, 2024 4.9315 0.0900 1.86% 4.8415 5.5615 4.8015
Feb 27, 2024 4.8815 -0.0100 -0.20% 4.8915 5.0515 4.7915
Feb 26, 2024 4.8715 0.1900 4.06% 4.6815 4.9815 4.6815
Feb 23, 2024 4.6815 0.2500 5.64% 4.4315 4.7515 4.4215
Feb 22, 2024 4.4815 -0.0900 -1.97% 4.5715 4.7615 4.4415
Feb 21, 2024 4.6615 -0.1000 -2.10% 4.7615 4.9215 4.5415
Feb 20, 2024 4.8515 -0.3000 -5.82% 5.1515 5.6315 4.6315

Black Diamond Therapeutics, Inc. Events

Time (UTC) Country Event
Tuesday, May 7, 2024

Time (UTC)

12:30

Country

US

Event

Q1 2024 Black Diamond Therapeutics Inc Earnings Release
Q1 2024 Black Diamond Therapeutics Inc Earnings Release

Forecast

-

Previous

-
Wednesday, May 15, 2024

Time (UTC)

13:00

Country

US

Event

Black Diamond Therapeutics Inc Annual Shareholders Meeting
Black Diamond Therapeutics Inc Annual Shareholders Meeting

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 0 0 0 0 0
Total Operating Expense 92.828 126.872 69.57 29.332 8.904
Selling/General/Admin. Expenses, Total 28.391 30.043 21.361 7.579 1.954
Research & Development 64.437 96.829 48.209 21.753 6.95
Unusual Expense (Income) 0
Operating Income -92.828 -126.872 -69.57 -29.332 -8.904
Interest Income (Expense), Net Non-Operating -0.219 3.464 4.041 -5.932 -0.011
Other, Net -0.354 -2.188 -1.725 0.006 -0.016
Net Income Before Taxes -91.169 -125.596 -67.254 -35.258 -8.931
Net Income After Taxes -91.169 -125.596 -67.254 -35.258 -8.931
Net Income Before Extra. Items -91.169 -125.596 -67.254 -35.258 -8.931
Net Income -91.169 -125.596 -67.254 -35.258 -8.931
Income Available to Common Excl. Extra. Items -91.169 -125.596 -67.254 -35.258 -8.931
Income Available to Common Incl. Extra. Items -91.169 -125.596 -67.254 -35.258 -8.931
Diluted Net Income -91.169 -125.596 -67.254 -35.258 -8.931
Diluted Weighted Average Shares 36.3256 36.189 32.9071 32.6364 32.6364
Diluted EPS Excluding Extraordinary Items -2.50977 -3.47056 -2.04375 -1.08033 -0.27365
Dividends per Share - Common Stock Primary Issue 0
Diluted Normalized EPS -2.57122 -3.47056 -2.04375 -1.08033 -0.27365
Gain (Loss) on Sale of Assets 2.232
Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
Total revenue 0 0 0 0 0
Total Operating Expense 20.032 21.561 21.852 22.124 23.173
Selling/General/Admin. Expenses, Total 6.878 6.808 7.243 6.277 6.978
Research & Development 13.154 14.753 14.609 15.847 16.195
Operating Income -20.032 -21.561 -21.852 -22.124 -23.173
Interest Income (Expense), Net Non-Operating 0.539 0.622 -1.573 0.562 0.386
Other, Net 0.341 0.064 0.115 -0.092 -0.143
Net Income Before Taxes -19.152 -20.875 -21.078 -21.654 -22.93
Net Income After Taxes -19.152 -20.875 -21.078 -21.654 -22.93
Net Income Before Extra. Items -19.152 -20.875 -21.078 -21.654 -22.93
Net Income -19.152 -20.875 -21.078 -21.654 -22.93
Income Available to Common Excl. Extra. Items -19.152 -20.875 -21.078 -21.654 -22.93
Income Available to Common Incl. Extra. Items -19.152 -20.875 -21.078 -21.654 -22.93
Diluted Net Income -19.152 -20.875 -21.078 -21.654 -22.93
Diluted Weighted Average Shares 36.5161 36.4839 36.3902 36.3462 36.2939
Diluted EPS Excluding Extraordinary Items -0.52448 -0.57217 -0.57922 -0.59577 -0.63179
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Diluted Normalized EPS -0.52448 -0.57217 -0.64056 -0.59577 -0.63179
Gain (Loss) on Sale of Assets 2.232
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total Current Assets 127.706 215.703 319.554 155.714 51.684
Cash and Short Term Investments 122.807 209.786 315.067 154.666 51.66
Cash & Equivalents 34.315 65.799 34.605 154.666 51.66
Prepaid Expenses 4.899 5.917 4.487 1.048 0.024
Total Assets 156.255 247.682 329.67 158.295 51.826
Property/Plant/Equipment, Total - Net 27.381 30.74 8.787 0.164 0.134
Property/Plant/Equipment, Total - Gross 28.131 31.109 8.951 0.276 0.234
Accumulated Depreciation, Total -0.75 -0.369 -0.164 -0.112 -0.1
Other Long Term Assets, Total 1.168 1.239 1.329 2.417 0.008
Total Current Liabilities 15.261 23.642 14.218 4.863 2.575
Accounts Payable 1.877 4.107 2.538 1.964 0.416
Accrued Expenses 13.384 19.535 11.68 2.899 0.452
Notes Payable/Short Term Debt 0 0 0 0 0
Other Current Liabilities, Total 0 1.707
Total Liabilities 40.56 51.782 21.912 4.879 6.598
Total Long Term Debt 0 0 0 0 0
Other Liabilities, Total 25.299 28.14 7.694 0.016 4.023
Total Equity 115.695 195.9 307.758 153.416 45.228
Preferred Stock - Non Redeemable, Net 0 0 60.77
Common Stock 0.005 0.005 0.005 0.001 0.001
Additional Paid-In Capital 452.503 440.129 425.363 3.812 0.169
Retained Earnings (Accumulated Deficit) -334.989 -243.82 -118.224 -50.97 -15.712
Total Liabilities & Shareholders’ Equity 156.255 247.682 329.67 158.295 51.826
Total Common Shares Outstanding 36.4343 36.2346 36.0784 32.6364 32.6364
Redeemable Preferred Stock 0 0 200.573
Short Term Investments 88.492 143.987 280.462
Other Equity, Total -0.414 0.614
Unrealized Gain (Loss) -1.824
Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
Total Current Assets 147.049 92.992 107.977 127.706 150.978
Cash and Short Term Investments 144.256 89.527 103.366 122.807 144.181
Cash & Equivalents 57.978 41.888 39.141 34.315 53.96
Short Term Investments 86.278 47.639 64.225 88.492 90.221
Prepaid Expenses 2.793 3.465 4.611 4.899 6.797
Total Assets 172.382 119.879 135.582 156.255 180.416
Property/Plant/Equipment, Total - Net 24.514 25.659 26.437 27.381 28.27
Property/Plant/Equipment, Total - Gross 25.252 26.618 27.282 28.131 28.98
Accumulated Depreciation, Total -0.738 -0.959 -0.845 -0.75 -0.71
Other Long Term Assets, Total 0.819 1.228 1.168 1.168 1.168
Total Current Liabilities 15.066 13.898 12.847 15.261 21.143
Accounts Payable 0.694 2.737 3.046 1.877 5.76
Accrued Expenses 14.372 11.161 9.801 13.384 15.383
Notes Payable/Short Term Debt 0 0 0 0 0
Total Liabilities 38.065 37.68 37.392 40.56 47.185
Total Long Term Debt 0 0 0 0 0
Other Liabilities, Total 22.999 23.782 24.545 25.299 26.042
Total Equity 134.317 82.199 98.19 115.695 133.231
Preferred Stock - Non Redeemable, Net 0 0 0 0
Common Stock 0.007 0.005 0.005 0.005 0.005
Additional Paid-In Capital 532.697 457.871 455.225 452.503 449.625
Retained Earnings (Accumulated Deficit) -398.023 -375.016 -355.864 -334.989 -313.911
Other Equity, Total -0.364 -0.661 -1.176 -1.824 -2.488
Total Liabilities & Shareholders’ Equity 172.382 119.879 135.582 156.255 180.416
Total Common Shares Outstanding 51.6352 36.5335 36.512 36.4343 36.3662
Redeemable Preferred Stock
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Net income/Starting Line -91.169 -125.596 -67.254 -35.258 -8.931
Cash From Operating Activities -85.082 -100.148 -52.146 -24.674 -8.454
Cash From Operating Activities 0.508 0.205 0.052 0.047 0.044
Non-Cash Items 15.48 18.223 10.014 10.074 0.079
Changes in Working Capital -9.901 7.02 5.042 0.463 0.354
Cash From Investing Activities 53.366 130.613 -281.691 -0.021 -0.076
Capital Expenditures -0.192 -2.71 -0.142 -0.021 -0.076
Other Investing Cash Flow Items, Total 53.558 133.323 -281.549 0
Cash From Financing Activities 0.177 0.729 214.944 127.756 52.312
Financing Cash Flow Items 0 -1.743 0
Issuance (Retirement) of Stock, Net 0.177 0.729 214.944 129.499 52.312
Issuance (Retirement) of Debt, Net 0
Net Change in Cash -31.539 31.194 -118.893 103.061 43.782
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Net income/Starting Line -20.875 -91.169 -70.091 -48.437 -25.507
Cash From Operating Activities -20.031 -85.082 -63.143 -46.667 -28.6
Cash From Operating Activities 0.122 0.508 0.382 0.253 0.125
Non-Cash Items 3.507 15.48 11.804 8.366 4.293
Changes in Working Capital -2.785 -9.901 -5.238 -6.849 -7.511
Cash From Investing Activities 24.806 53.366 51.044 36.537 16.729
Capital Expenditures 0 -0.192 -0.192 -0.2 -0.007
Other Investing Cash Flow Items, Total 24.806 53.558 51.236 36.737 16.736
Cash From Financing Activities 0.051 0.177 0.205 0.153 0.153
Issuance (Retirement) of Stock, Net 0.051 0.177 0.205 0.153 0.153
Net Change in Cash 4.826 -31.539 -11.894 -9.977 -11.718
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
Bellevue Asset Management AG Investment Advisor 16.5502 8535839 400000 2023-10-17 LOW
Versant Ventures Venture Capital 12.5047 6449348 0 2023-03-15 LOW
New Enterprise Associates (NEA) Venture Capital 8.6257 4448757 1000000 2023-06-30 LOW
RA Capital Management, LP Hedge Fund 6.8361 3525754 935850 2023-06-30 LOW
Invus Public Equities Advisors, LLC Investment Advisor 3.968 2046517 400000 2023-06-30 MED
Boxer Capital, L.L.C. Hedge Fund 3.9066 2014858 0 2023-06-30 LOW
Point72 Asset Management, L.P. Hedge Fund 3.8778 2000000 2000000 2023-06-30 HIGH
Deerfield Management Company, L.P. Hedge Fund 3.49 1800000 1800000 2023-06-30 MED
RTW Investments L.P. Investment Advisor/Hedge Fund 3.2961 1700000 1700000 2023-06-30 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 2.8723 1481385 723800 2023-06-30 LOW
Citadel Advisors LLC Hedge Fund 2.3566 1215408 657637 2023-06-30 LOW
J.P. Morgan Securities LLC Research Firm 2.0931 1079507 1079507 2023-06-30 MED
BlackRock Financial Management, Inc. Investment Advisor/Hedge Fund 1.8323 945039 761641 2023-06-30 LOW
Epstein (David M) Individual Investor 1.7712 913479 -25000 2023-06-27 LOW
Ally Bridge Group NY LLC Hedge Fund 1.5511 800000 800000 2023-06-30 HIGH
Kennedy Capital Management, Inc. Investment Advisor 1.4569 751403 751403 2023-06-30 MED
Heights Capital Management, Inc. Investment Advisor 1.4542 750000 750000 2023-06-30 HIGH
Cowen Investment Management LLC Investment Advisor/Hedge Fund 1.4542 750000 750000 2023-06-30 HIGH
Driehaus Capital Management, LLC Investment Advisor/Hedge Fund 1.3514 696969 685952 2023-06-30 MED
Rock Springs Capital Management LP Hedge Fund 1.0921 563233 563233 2023-06-30 LOW

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Black Diamond Therapeutics, Inc. Company profile

Black Diamond Therapeutics, Inc., a biotechnology company, discover and develops small molecule, tumor-agnostic therapies. Its lead product candidate is BDTX-189, an irreversible small molecule inhibitor that is designed to block the function of family of oncogenic proteins defined by driver mutations across a range of tumor types, and which affect the epidermal growth factor receptor (EGFR), the tyrosine-protein kinase, or human epidermal growth factor receptor 2. The company is also developing BDTX-1535, a brain-penetrant inhibitor of EGFR mutations, including allosteric and canonical EGFR mutations; and various early stage pipeline programs of allosteric mutations in kinases related to cancer and/or rare genetic diseases. It has a strategic partnership with OpenEye Scientific Software, Inc. The company was formerly known as ASET Therapeutics, Inc. and changed its name to Black Diamond Therapeutics, Inc. in January 2018. Black Diamond Therapeutics, Inc. was founded in 2014 and is headquartered in Cambridge, Massachusetts.
Industry: Bio Therapeutic Drugs

One Main Street, 14th Floor
CAMBRIDGE
MASSACHUSETTS 02142
US

Income Statement

  • Annual
  • Quarterly

News

Bank of Japan Preview: will the BOJ end negative interest rates?

The Bank of Japan meets on Tuesday 19th of March. We preview what to expect from the BOJ decision and how it might impact the USD/JPY and Nikkei 225.

08:44, 18 March 2024

Higher CPI leaves traders unfazed as US equities continue to build momentum

The latest US CPI reading hasn’t gone how the Federal would have hoped. Consumer prices came in higher than expected in February for the third month in a row.

12:42, 15 March 2024

Four reasons why Bitcoin is surging to record highs

Bitcoin has surged to record highs. We discuss the four factors pushing Bitcoin higher and analyse the technicals of the cryptocurrency’s technicals.

10:18, 14 March 2024

China’s National People’s Congress: The markets have again been left wanting more

China’s National People’s Congress (NPC) is underway, and the markets have so far been disappointed by what’s been delivered by the country’s central government. We look at some of the significant takeaways from the event, discuss China’s current economic conditions, and analyse the China A50.

08:23, 8 March 2024
Facade on the Federal Reserve Building in Washington DC

Central Banks: which one will cut first?

Central banks dominate the calendar in March and markets try to anticipate which one will be the first one to cut

13:14, 6 March 2024

Nvidia (NVDA) confronts high expectations for Q4 results

Nvidia is arguably the hottest company on the planet. The company reports its Q4 results after the closing bell on Wednesday, the 21st of February. We preview what to expect from Nvidia’s earnings and analyse the technicals of its stock price.

12:13, 20 February 2024

UK Bank Earnings: What to expect from Lloyds, Barclays and HSBC?

UK banks will be in the spotlight in the week ahead as the European earnings season continues

16:38, 16 February 2024

People also watch

US100

17,937.20 Price
+0.680% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0040%
Overnight fee time 22:00 (UTC)
Spread 1.8

Oil - Crude

82.05 Price
+1.730% 1D Chg, %
Long position overnight fee 0.0269%
Short position overnight fee -0.0488%
Overnight fee time 22:00 (UTC)
Spread 0.030

BTC/USD

65,923.55 Price
-3.420% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 106.00

Gold

2,161.74 Price
+0.270% 1D Chg, %
Long position overnight fee -0.0188%
Short position overnight fee 0.0106%
Overnight fee time 22:00 (UTC)
Spread 0.30

Still looking for a broker you can trust?

Join the 580.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading